Long-Term Safety and Efficacy of Teneligliptin in Elderly Patients With Type 2 Diabetes: Subgroup Analysis of a 3-Year Post-Marketing Surveillance in Japan

Advances in Therapy - United States
doi 10.1007/s12325-020-01306-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Safety and Effectiveness of Istradefylline in Patients With Parkinson’s Disease: Interim Analysis of a Post-Marketing Surveillance Study in Japan

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2018English

Impact of Body Mass Index on the Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes Mellitus: A Subgroup Analysis of 3‐month Interim Results From the STELLA ‐ LONG TERM Study

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2019English

Real-World Evidence for the Safety of Ipragliflozin in Elderly Japanese Patients With Type 2 Diabetes Mellitus (STELLA-ELDER): Final Results of a Post-Marketing Surveillance Study

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2016English

Efficacy and Safety of Imarikiren in Patients With Type 2 Diabetes and Microalbuminuria

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2019English

Two-Year Pulmonary Safety and Efficacy of Inhaled Human Insulin (Exubera) in Adult Patients With Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2008English

Safety and Efficacy of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis: A Nationwide Post-Marketing Surveillance Study in Korean Patients

Advances in Therapy
MedicinePharmacology
2020English

Exploratory Analysis of Comparative Clinical Trials Used for Marketing Approval in Patients With Type 2 Diabetes in Japan

SAGE Open Medicine
Medicine
2019English

Comparison of Teneligliptin and Atorvastatin on Lipid Profile in Patients With Type 2 Diabetes Mellitus

Current Research in Diabetes & Obesity Journal
2018English

Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment With a Prospective Post-Marketing Surveillance Study

Drugs - Real World Outcomes
Pharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy